A SURVEY OF USING ANTIBIOTICS IN OUTPATIENT TREATMENT COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN FROM 6 MONTHS TO 5 YEARS OLD AT MILITARY HOSPITAL BAC LIEU IN 2020
Main Article Content
Abstract
Pneumonia is a major cause of hospitalization and death in children with acutely respiratory
infections. Children under 5 years old, especially those under 2 months old are subjects who take
the highest risk of illness and death from pneumonia. Bacteria are the most common cause of the
disease. Therefore, antibiotics play an important and indispensable role in treatment to reduce the
mortality rate of pneumonia. The analyses and assessments of the current situations about antibiotic
are extremely necessary, helping clinicians and managers to formulate and implement strategies for
safe and rational usage of antibiotics. At the same time, they are also to improve the effectiveness
of community-acquired pneumonia treatment for children. In the study, there were 63 children with
pneumonia, including 37 (58.73%) boys and 26 (41.27%) girls. Children with the age of 6-12 months
suffer from the illness the most 25 (39.68%), the group 48-60 months come down with the disease the
least 4 (6.35%). The rate of children diagnosed with code J18 (pneumonia, non-specific agent) was
the highest at 28 (44.44%). Children with pneumonia were hospitalized mainly in February (31.75%).
The group of antibiotics used for treatment is the Beta-lactam group, Amoxicillin/clavuclanic acid is
the most prescribed antibiotic 55 (87.3%). This antibiotic has 4 brand names, in which Klamentin is
used the most 27 (42.86%). The origin of antibiotics is mainly from Vietnam. The antibiotics used
are 100% oral. Antibiotic in sachets accounts for the highest percentage (68.25%).
Article Details
Keywords
Pneumonia, children, Bac Lieu.
References
pediatrics. Medical Publishing House, 2020.
[2] Ministry of Health, Guidelines for the
management of community-acquired pneumonia
in children, 2014.
[3] Ministry of Health, Guidelines for diagnosis
and treatment of some common diseases in
children, 2015.
[4] Ministry of Health, Guidelines for using antibiotic
in children, 2015.
[5] Vietnam Respiratory Society, Vietnam Pediatric
Association, Recommended for diagnosis and
treatment of childhood respiratory infections, 2018.
[6] Vietnam Association of Tuberculosis and Lung
Disease, Community-acquired Pneumonia and
COPD exacerbations, Journal of Respiratory,
2018; 15(5):2-28.
[7] Vietnam Association of Tuberculosis and Lung
Disease, Standard practice in hospital and good
management in the community in the respiratory
specialist, Journal of Respiratory, 2019.
[8] Van HP, Thanh NV, Ngoc TV et al., Pathogens
causing hospitalized community acquired
pneumonia results from REAL study 2016-2017,
Journal of Medical Research, 2017; 22(1).
[9] Tuan TA, Community-acquired pneumonia in
children, current inadequacies and solutions.
Presented at Hai Phong Respiratory Conference,
Vietnam, 2019.
[10] Trang LV, Research on the causes of the disease
and risk factors in children with pneumonia
lasting more than 2 weeks at the Respiratory
Department, Thanh Hoa Children’s Hospital,
Journal of Pediatric Research and Practice,
2016; 4(1).